Will OpenAI or Anthropic IPO first?
I assess a very high probability (94%) that at least one of OpenAI or Anthropic will have completed an IPO before 2040 — Anthropic is the likelier near-term candidate, OpenAI is plausible but structurally more complicated.
Analysis
**Stage 1 — Blind analysis (ignore market price):**
- Time horizon is long (to 2040). Over a 14+ year window, it is historically common for major, well‑capitalized tech companies to either go public or be acquired. Both OpenAI and Anthropic are large, fundraising‑intensive AI firms with strong incentives to access public equity, liquidity for early investors/employees, and reputational/value benefits from a public listing.
- **Anthropic**: Founded more recently but structured as a for‑profit startup with classic VC backing and reported rumor‑level preparation for a 2026 IPO. That rumor (even if not a filing) signals management and investors are at least discussing a public posture. Anthropic’s cap table and corporate form make an IPO a straightforward option. Over a 14‑year horizon, probability Anthropic IPOs at some point before 2040 is high (I would place it >80%).
- **OpenAI**: Corporate structure is atypical — a nonprofit parent with a capped‑profit subsidiary, a large strategic equity stake held by Microsoft, and governance that emphasizes mission constraints. That makes an IPO less straightforward and could delay or complicate a classic S‑1 listing. However, OpenAI also faces enormous capital needs for compute and may find public markets attractive; Microsoft’s role could take the firm public (via a spin, direct listing, or other transaction) or keep it private via sustained strategic funding. I estimate OpenAI’s standalone IPO probability by 2040 ~70–80%, but with more structural uncertainty than Anthropic.
- Combining those assessments: the chance that neither company IPOs by 2040 is small — it would require both to be acquired (and remain private as subsidiaries), to be blocked by regulation or nationalization, or to deliberately avoid public markets indefinitely. Those outcomes are possible but unlikely across both firms. I therefore assess a high independent probability (~94%) that at least one of them will IPO before 2040.
- Key qualitative drivers supporting a high probability: massive capital intensity of frontier AI, liquidity pressures for employees/investors, precedent effects (other mega‑unicorns IPO over multi‑year windows), and public market appetite for AI exposure.
- Key qualitative constraints lowering probability: OpenAI’s unusual governance and Microsoft tie, potential strategic acquisitions of either firm (which produce a No for this market), and stronger regulatory scrutiny over AI by some jurisdictions.
**Stage 2 — Market calibration (look at current market price: Yes = 0.77):**
- The market currently prices ~77% that at least one of them will IPO before 2040, which is meaningfully below my independent 94% estimate. Possible reasons the market is lower: - **Ambiguity/interpretation risk**: Some traders may be interpreting the question narrowly (e.g., which will IPO *first* between them rather than *whether either will IPO*), or expect simultaneity/acquisition outcomes that make the market less confident. Confusing wording can depress the price even if the true chance is higher. - **Acquisition tail**: Market participants may overweight the possibility that both companies are acquired by strategic buyers (Microsoft, big cloud players, national champions) rather than going public — acquisitions are common exit routes and would produce a No here. That risk reduces the market price relative to my view. - **Regulatory and geopolitical uncertainty**: Traders might assign more weight to potential regulatory roadblocks (export controls, limits on listing, national security actions) across a long timespan. - **Time‑discounting / risk aversion**: For very long‑dated events, traders often shrink probabilities toward 50–80% because of model uncertainty and the many unpredictable macro/regulatory/tech regime changes over 14 years.
- Overall, I think the market is *conservatively* priced and that the 0.77 level understates the near‑certainty implied by the firms' capital needs and standard exit paths. That said, the market is not wildly distant — 77% still reflects a strong consensus for Yes — but my independent view is materially higher because the combination of two independent-ish opportunities makes the 'neither IPOs' scenario quite unlikely.
- Trading implication: if you believe my 94% is correct, the market at 77% represents a reasonable arbitrage if transaction costs and timing permit — though liquidity, question interpretation, and event adjudication rules should be checked before acting.
Arguments
For
- Strong economic incentives to access public markets for massive, ongoing compute and investment needs.
- Anthropic has public signals (rumors of 2026 preparation) indicating management/investor conversations about an IPO.
- Historical pattern: large, well‑funded unicorns typically either IPO or are acquired within a 10–15 year window.
- Positive market appetite for AI exposure — demonstrated by high valuations and precedent IPOs (and the SpaceX IPO ripple effect).
Against
- OpenAI’s governance and Microsoft’s strategic stake complicate a straightforward IPO path; it could remain private or be spun out differently.
- Both firms are attractive acquisition targets for deep-pocketed strategics who may prefer to buy rather than allow a public listing.
- Regulatory or geopolitical shocks could delay or prevent public offerings by major AI firms, especially cross‑border listings.
- Rumors and social posts (e.g., Instagram claims) are weak signals; absence of formal filings so far adds near‑term uncertainty.
Key drivers
- Capital intensity of frontier AI (compute costs and R&D) driving need for public capital or large strategic partnerships.
- Corporate structure and governance differences: OpenAI's capped‑profit model and Microsoft stake vs Anthropic’s more traditional VC backing.
- M&A interest from strategic tech players (Microsoft, cloud providers) which can substitute for an IPO and produce a No.
- Regulatory/geopolitical developments over the next 14 years that could restrict IPOs or cross‑border financing.
Risk factors
- Acquisition risk: a strategic buyer could purchase one or both companies pre‑IPO, creating a No outcome.
- Structural/governance roadblocks: OpenAI’s unusual legal structure and nonprofit ties could delay or preclude a traditional IPO.
- Regulatory intervention: national security or AI‑specific restrictions could block or delay public listings in certain jurisdictions.
- Long‑horizon uncertainty: macro, market, or technology paradigm shifts between now and 2040 that change exit incentives.
Scenarios
Best case
Anthropic proceeds to an IPO in the near‑to‑medium term (e.g., 2026–2030), and OpenAI either follows later or is taken public via a structured listing; at least one public listing occurs early, confirming market expectations and delivering the Yes outcome well before 2040.
Most likely
At least one of the two (most likely Anthropic) completes an IPO by the mid‑2030s; the other either IPOs later, pursues a strategic sale, or stays private under strategic funding. Net outcome: Yes (at least one IPO) occurs well before 2040.
Worst case
Both companies are acquired by strategic buyers (or otherwise absorbed into larger entities) or blocked by regulation so that neither completes a public offering before 2040 — producing a No outcome. This requires multiple low‑probability events across both firms but is the principal pathway to No.
More from this day
- CompaniesKalshi1y
Starbucks total global stores in 2026
AI55%MKT8%Edge+47Hidden GemGiven Starbucks' stated expansion plan, the Q2 2026 U.S. store count, and plausible China growth, I assess a better-than-even chance that total global stores will exceed 41,800 in 2026 — despite the market strongly favoring No.
- HealthKalshi2y
What will the average number of measles cases be during Trump's term?
AI72%MKT30%Edge+42Hidden GemAssuming 'Yes' means the average annual U.S. measles cases during 2025–2028 exceeds 1,000, I assess a ~72% chance that the average will be above that threshold, driven by the large 2026 surge and persistent immunity gaps that make further large outbreaks likely.
- PoliticsKalshi18y
Which G7 leader will leave next?
AI52%MKT94%Edge-42HypedI assess that the UK Prime Minister (Keir Starmer) is the most likely of the five listed G7 leaders to be the first to leave office, but not as overwhelmingly as the market currently prices — my independent probability is 52%.